Pharmacists in Alabaster, Alabama


44 Pharmacists found in Alabaster
female pharmacist

Leigh Anne Marshall


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
250 S Colonial Dr, Alabaster, AL 35007
205-564-2609     205-564-2854

female pharmacist

Lisa Marie Roberson, PHARM D


Pharmacist
205 Buck Creek Plz, Alabaster, AL 35007
205-621-0069     205-621-1774

female pharmacist

Oona Ward, PHARM D


Pharmacist
250 S Colonial Dr, Alabaster, AL 35007
205-564-2609    



male pharmacist

Patrick Dale Jones, PHARM D


Pharmacist
9085 Highway 119, Alabaster, AL 35007
205-624-6224    

female pharmacist

Dr. Rachel Ann Meinberg, PHARM.D.


Pharmacist
140 Market Center Dr, Alabaster, AL 35007
205-663-4500    

female pharmacist

Stephanie Avant


Pharmacist
1000 1st St N, Alabaster, AL 35007
205-620-8878    

male pharmacist

Stephen John Newton, R.PH.


Pharmacist
514 1st St N, Alabaster, AL 35007
205-621-2310    

male pharmacist

Mr. Stephen Keith Levan, RPH


Pharmacist
1022 Fisrt Street North, Alabaster, AL 35007
205-621-2310    

male pharmacist

Steven Crainich, R.PH.


Pharmacist
9301 Highway 119, Alabaster, AL 35007
205-664-4584     205-664-5095

female pharmacist

Stormy Leigh O'bryant, PHARMD


Pharmacist - Pharmacotherapy
1000 1st St N, Alabaster, AL 35007
205-620-8188     205-620-8889

female pharmacist

Tionna Dickinson, PHARMACIST


Pharmacist
140 Market Center Dr, Alabaster, AL 35007
205-663-4500     205-663-4501

female pharmacist

Trina Defranco, RPH


Pharmacist
630 Colonial Promenade Pkwy, Alabaster, AL 35007
205-663-3411     205-663-3485


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.